ES2109225T3 - Anticuerpos, su produccion y uso. - Google Patents

Anticuerpos, su produccion y uso.

Info

Publication number
ES2109225T3
ES2109225T3 ES90116234T ES90116234T ES2109225T3 ES 2109225 T3 ES2109225 T3 ES 2109225T3 ES 90116234 T ES90116234 T ES 90116234T ES 90116234 T ES90116234 T ES 90116234T ES 2109225 T3 ES2109225 T3 ES 2109225T3
Authority
ES
Spain
Prior art keywords
polypeptide
antibody
formula
acid sequence
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90116234T
Other languages
English (en)
Inventor
Kazuo Nakahama
Tsunehiko Fukuda
Tsutomu Kurokawa
Ken-Ichi Kuroshima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ES2109225T3 publication Critical patent/ES2109225T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/48Nerve growth factor [NGF]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • C07K14/625Extraction from natural sources
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE MUESTRA (A) UN ANTICUERPO PEPTIDO QUE INCLUYE AL MENOS OCHO AMINOACIDOS SUCESIVAMENTE, DE UN ACIDO REPRESENTADO CONSECUTIVAMENTE POR FORMULA (1): **FORMULA** (B) UN METODO PARA PRODUCIR ANTICUERPOS, (C) UN CLONE HIBRIDO QUE PRODUCE EL ANTICUERPO, (D) UN METODO PARA PRODUCIR UN CLONE HIBRIDO,(E) UN PETIDO DE UN POLIPEPTIDO (1) INCLUYENDO UN AMINOACIDO REPRESENTADO CONSECUTIVAMENTE POR FORMULA (1), (F) UN PEPTIDO ENLAZADO, QUE LLEVA AL MENOS OCHO AMINOACIDOS SUCESIVAMENTE DE FORMULA (1), CON UNA PROTEINA PORTADORA (G) Y UN METODO PARA PURIFICACION DEL POLIPEPTIDO (1) Y (H) UN METODO PARA DETECTAR Y ENSAYAR EL POLIPEPTIDO
ES90116234T 1989-08-28 1990-08-24 Anticuerpos, su produccion y uso. Expired - Lifetime ES2109225T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21871189 1989-08-28
JP13405890 1990-05-25

Publications (1)

Publication Number Publication Date
ES2109225T3 true ES2109225T3 (es) 1998-01-16

Family

ID=26468244

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90116234T Expired - Lifetime ES2109225T3 (es) 1989-08-28 1990-08-24 Anticuerpos, su produccion y uso.

Country Status (7)

Country Link
EP (1) EP0418590B1 (es)
AT (1) ATE160288T1 (es)
CA (1) CA2024063C (es)
DE (1) DE69031726T2 (es)
DK (1) DK0418590T3 (es)
ES (1) ES2109225T3 (es)
GR (1) GR3025835T3 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1243281B (it) * 1990-06-12 1994-05-26 Fidia Spa Metodo per la determinazione quantitativa e qualitativa di polipeptidiin liquidi proteici
US5958875A (en) * 1996-03-29 1999-09-28 The Regents Of The University Of California Synthetic peptides derivatives with nerve growth factor-like neurotrophic activity
PT2270048E (pt) 2002-12-24 2016-02-10 Rinat Neuroscience Corp Anticorpos anti-ngf e métodos de utilização dos mesmos
US9498530B2 (en) 2002-12-24 2016-11-22 Rinat Neuroscience Corp. Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
US7655231B2 (en) 2003-02-19 2010-02-02 Pfizer Inc. Methods for treating pain by administering a nerve growth factor antagonist and an NSAID
EA013614B1 (ru) 2003-07-15 2010-06-30 Амджен Инк. Изолированное антитело к фактору роста нервов (ngf) и способы его применения
HUE037549T2 (hu) 2004-04-07 2018-09-28 Rinat Neuroscience Corp Eljárások csontrákfájdalom kezelésére idegi növekedési faktor antagonista antitest beadásával
ME00226B (me) 2004-07-15 2011-02-10 Medarex Llc Humana anti-ngf neutrališuća antitijela kao selektivni inhibitori ngf signalne kaskade
JP2012515158A (ja) 2009-01-12 2012-07-05 武田薬品工業株式会社 癌の予防・治療剤

Also Published As

Publication number Publication date
DE69031726D1 (de) 1998-01-02
CA2024063A1 (en) 1991-03-01
ATE160288T1 (de) 1997-12-15
EP0418590B1 (en) 1997-11-19
DK0418590T3 (da) 1998-04-20
DE69031726T2 (de) 1998-03-12
CA2024063C (en) 2002-07-16
JPH04128298A (ja) 1992-04-28
EP0418590A1 (en) 1991-03-27
GR3025835T3 (en) 1998-04-30

Similar Documents

Publication Publication Date Title
Giri et al. Studies on the synthesis and secretion of interleukin 1. I. A 33,000 molecular weight precursor for interleukin 1.
ATE88572T1 (de) Antikoerper gegen polypeptide, die gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure oder kodierender nukleotidsequenz komplementaer sind und diesbezuegliches aufbauverfahren.
AU564620B2 (en) Peptides and protein-peptide complexes
LU91013I2 (fr) ReFacto (Moroctocog alfa) dans toutes ses formes couvertes par le brevet de base
ES2109225T3 (es) Anticuerpos, su produccion y uso.
KR900012626A (ko) 하이브리드 단백질, 이의 생산방법 및 이를 함유하는 약제학적 조성물
WO1995020764A1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
NO850087L (no) Bestemmelse av fibrin med fibrin-spesifikke antistoffer
DE69434741D1 (de) Reagenzien für die Diagnose von rheumatoiden Arthritis
KR890012669A (ko) 심방 나트륨이뇨성 폴리펩티드를 인지하는 단일클론성 항체
JPS5767858A (en) Immunochemical measurement method for human chorionic gonadotropin and production of antibody
Yanaihara et al. Synthesis of proinsulin. III. Synthesis of polypeptides related to the connecting peptide segment of bovine proinsulin
NO904129D0 (no) Antistoffer mot hoeykonserverte aminosyresekvenser fra immunogene forbindelser, fremgangsmaate for fremstilling av antistoffer samt anvendelse derav i immunoanalyser.
ATE110853T1 (de) Immuntestverfahren für zelluläres eiweiss.
ATE88639T1 (de) Antigenisches peptid der 28kd proteingruppe aus s. mansoni und sein verfahren zur isolierung, monoklonale antikoerper, die mindestens ein epitop dieses peptids erkennen und verwendungen fuer die induzierung der synthese von neutralisierenden antikoerpern.
DE3827416A1 (de) Peptide mit prourokinase-sequenzen, verfahren zu ihrer herstellung und ihre verwendung, antikoerper gegen diese peptide und mittel enthaltend diese antikoerper zur bestimmung von prourokinase

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 418590

Country of ref document: ES